- Associated Press•16 hours ago
Federal regulators have approved a first-of-a-kind "artificial pancreas," a device that can help some diabetes patients manage their disease by constantly monitoring their blood sugar and delivering ...
- The Wall Street Journal•17 hours ago
The U.S. Food and Drug Administration said it has approved an insulin pump by medical device company Medtronic that automatically manages glucose levels within a target range.
Medtronic plc (MDT)
NYSE - NYSE Real Time Price. Currency in USD
|Bid||85.05 x 200|
|Ask||85.66 x 200|
|Day's Range||85.06 - 87.46|
|52wk Range||66.35 - 89.27|
|1y Target Est||N/A|
Trade prices are not sourced from all markets
|P/E Ratio (ttm)||33.23|
|Avg Vol (3m)||4,224,765|
|Dividend & Yield||1.72 (1.98%)|